A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/1998
12/02/1998	EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998	EP0880354A1 Urogenital and intestinal compositions
12/02/1998	CN1200674A Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
12/02/1998	CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998	US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998	US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998	US5843976 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
12/01/1998	US5843972 Heterocyclic β-adrenergic agonists
12/01/1998	US5843965 Benzo B! thiophene compounds, intermediates, processes, compositions, and methods
12/01/1998	US5843962 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
12/01/1998	US5843961 Method and composition for treating erectile dysfunction
12/01/1998	US5843947 N-pyridyl carboxamides and derivatives
12/01/1998	US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
12/01/1998	US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998	CA2026216C Optically active benzyl alcohol compound and the use thereof
11/1998
11/29/1998	CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia
11/26/1998	WO1998053071A1 Modulators of tissue regeneration
11/26/1998	WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998	WO1998052946A1 Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
11/26/1998	WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998	WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998	WO1998052929A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
11/26/1998	WO1998052906A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998	WO1998052586A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease
11/26/1998	WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998	CA2290831A1 New nitromethyl ketones, process for preparing them and compositions containing them
11/26/1998	CA2290783A1 Modulators of tissue regeneration
11/26/1998	CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998	CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998	CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/25/1998	EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production
11/25/1998	EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1
11/25/1998	EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998	EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998	EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998	EP0879233A1 Chinoline and benzimidazole derivatives as bradykinin agonists
11/25/1998	EP0879053A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrom x
11/25/1998	EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998	CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998	CN1200035A Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
11/24/1998	US5840871 Pure polynucleotide sequence as hybridization probes complementary to the polynucleotide; transformed cell cultures yield protein; possible anticancer agents for breast and cell cancer
11/24/1998	US5840857 Purification of post-menopausal urinary concentrate by immunochromatography and reverse phase high pressure liquid chromatography; biologically active product is free from lutenizing hormone and other proteins; fertility agents
11/24/1998	US5840754 Dosage form comprising oxybutynin
11/24/1998	US5840747 Calcium channel antagonists
11/24/1998	US5840722 Administering to inhibit endothelin receptors
11/24/1998	US5840712 Water soluble vitamin B12 receptor modulating agents and methods related thereto
11/24/1998	US5840701 Antiischemic agents and macomolecules
11/24/1998	US5840311 Administering hepatocyte growth factors to treat fibrosis disorder; increases collagenase activity
11/24/1998	US5840299 Binding and treatment of multiple sclerosis
11/23/1998	CA2232808A1 Novel compounds
11/23/1998	CA2230996A1 Novel compounds
11/23/1998	CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998	CA2231017A1 A member of the frzb family, frazzled
11/22/1998	CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/19/1998	WO1998051664A1 3-epi vitamin d2 compounds and uses thereof
11/19/1998	WO1998051335A1 Methods of modulating immune coagulation
11/19/1998	WO1998051314A1 Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder
11/19/1998	WO1998051298A1 Arylsubstituted piperazines useful in the treatement of benign prostatic hyperlasia
11/19/1998	DE19719680A1 Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz Use of diphosphonic acids for the preventive treatment of sequelae in bladder extension or bladder replacement
11/19/1998	CA2288710A1 3-epi vitamin d2 compounds and uses thereof
11/18/1998	EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998	EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/18/1998	EP0877734A1 Quinoline and quinazoline compounds useful in therapy
11/18/1998	EP0877623A1 Intranasal vaccination against gastrointestinal disease
11/18/1998	EP0877616A1 Medicaments containing aromatic azo compounds
11/18/1998	EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
11/17/1998	US5837702 4-arylamino-benzopyran and related compounds
11/17/1998	US5837508 Hce3p83 polypeptides and polynucleotides used in the design of protocols for treatment of alzheimer's disease, stroke, cancer, inflammation, arthritis, musculoskeletal disease, heart disease, kidney disease and diagnostic assays for such
11/17/1998	US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998	US5837451 Identifying composition which affect kinase activity
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050381A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998	WO1998050356A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	WO1998050060A1 Therapies for acute renal failure
11/12/1998	WO1998050038A1 Use of quinazoline compounds for the treatment of polycystic kidney disease
11/12/1998	CA2289123A1 Therapies for acute renal failure
11/12/1998	CA2289102A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	CA2289001A1 Novel heterocyclic compounds
11/11/1998	EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998	EP0876815A1 "Drug delivery system for two or more active substances"
11/11/1998	EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998	EP0876379A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
11/11/1998	EP0876359A1 (-) cis-6(s)-phenyl-5(r) 4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate
11/11/1998	EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998	CN1198735A Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof
11/11/1998	CN1198344A Oral liquor for curing urethritis
11/11/1998	CN1040646C Enatiomeric hydroxylated xanthine compound
11/10/1998	US5834521 Treatment of progestin mediated maladies; osteoporosis, cancer
11/10/1998	US5834504 Modulating, inhibiting abnormal cell proliferation; enzyme inhibition
11/10/1998	US5834483 Method of treating heart failure with endothelin antagonists
11/10/1998	US5834469 Endothelin receptor antagonists
11/07/1998	CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998	WO1998049319A1 Human lysophospholipase
11/05/1998	WO1998049166A1 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
11/05/1998	WO1998049162A1 Sulfonamides for treatment of endothelin-mediated disorders
11/05/1998	WO1998048786A1 AMINOTETRALINS AS 5-HT1Dα AGONISTS
11/05/1998	CA2288897A1 Aminotetralins as 5-ht1d.alpha. agonists
11/05/1998	CA2288073A1 Human lysophospholipase
11/04/1998	EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998	EP0875573A2 CRFG-1b, a target and marker for chronic renal failure

1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 562